Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells-Reference-Cited by-同舟云学术

Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells

Published:2005-09-08 Issue:4 Volume:118 Page:857-868
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Brew Christine T.,Aronchik Ida,Hsu Jocelyn C.,Sheen Joon-Ho,Dickson Robert B.,Bjeldanes Leonard F.,Firestone Gary L.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference62 articles.

1. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol;Grubbs;Anticancer Res,1995

2. Effects of dietary indole-3- carbinol on estradiol metabolism and spontaneous mammary tumors in mice;Bradlow;Carcinogenesis,1991

3. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles;Wattenberg;Cancer Res,1978

4. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling;Cover;J Biol Chem,1998

5. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter;Cram;J Biol Chem,2001

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDM2: current research status and prospects of tumor treatment;Cancer Cell International;2024-05-13

2. Dynamic Profile of the Yak Mammary Transcriptome during the Lactation Cycle;Animals;2023-05-22

3. Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma;ACS Omega;2023-01-26

4. Indole-3-Carbinol Stabilizes p53 to Induce miR-34a, Which Targets LDHA to Block Aerobic Glycolysis in Liver Cancer Cells;Pharmaceuticals;2022-10-13

5. Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death;International Journal of Molecular Sciences;2022-04-30